Funding for this research was provided by:
National Human Genome Research Institute (R00HG007076)
Article History
Received: 28 October 2019
Accepted: 14 June 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: The study protocol was reviewed by the University of Washington Human Subjects Division and determined to qualify for exempt (category 2) status (STUDY00006646).
: Not applicable.
: MD is a co-inventor of the Cleveland Clinic’s MyLegacy intellectual property portfolio, now licensed to Family Care Path, Inc. As part of this license, she is entitled to a share in both royalties and returns on equity. JHY is a member of Sage Bionetworks Scientific Advisory Board.